Literature DB >> 11903208

Clinical correlates of psychiatric comorbidity in bipolar I patients.

E Vieta1, F Colom, B Corbella, A Martínez-Arán, M Reinares, A Benabarre, C Gastó.   

Abstract

OBJECTIVES: To ascertain the clinical implications of psychiatric comorbidity in the course and outcome of bipolar I patients.
METHODS: One hundred and twenty-nine bipolar I outpatients in remission [Young Mania Rating Scale (Y-MRS) < 7, Hamilton Depression Rating Scale (HDRS) < 9] were assessed by means of the Structured Clinical Interview for DSM-III-R axis I and axis II (SCID-I and SCID-II) in order to detect all possible psychiatric comorbid diagnoses. The sample was split according to the presence of psychiatric comorbidity and the groups were compared.
RESULTS: Psychiatric comorbidity was detected in 31% of the sample. A higher number of mixed features, depressive episodes and suicide attempts and a predominance of depressive onset amongst comorbid bipolar patients were the most relevant differences between the two groups.
CONCLUSIONS: There is an association between depression, suicidality and comorbidity in bipolar I disorder. As comorbidity had a clear relevance in the course and outcome of bipolar illness, this issue should be specifically assessed in clinical practice.

Entities:  

Mesh:

Year:  2001        PMID: 11903208

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  25 in total

1.  Asenapine in the management of impulsivity and aggressiveness in bipolar disorder and comorbid borderline personality disorder: an open-label uncontrolled study.

Authors:  Andrea Aguglia; Ludovico Mineo; Alessandro Rodolico; Maria S Signorelli; Eugenio Aguglia
Journal:  Int Clin Psychopharmacol       Date:  2018-05       Impact factor: 1.659

Review 2.  Problematic boundaries in the diagnosis of bipolar disorder: the interface with borderline personality disorder.

Authors:  Mark Zimmerman; Theresa A Morgan
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

Review 3.  The significance of mixed states in depression and mania.

Authors:  Giulio Perugi; Giuseppe Quaranta; Liliana Dell'Osso
Journal:  Curr Psychiatry Rep       Date:  2014-10       Impact factor: 5.285

4.  Undiagnosed Bipolar Disorder: New Syndromes and New Treatments.

Authors:  Ira D Glick
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

Review 5.  A critical update on psychological interventions for bipolar disorders.

Authors:  Eduard Vieta; Isabella Pacchiarotti; Marc Valentí; Lesley Berk; Michael Berk; Jan Scott; Francesc Colom
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

Review 6.  Epidemiology and management of anxiety in patients with bipolar disorder.

Authors:  Marcia Kauer-Sant'Anna; Flavio Kapczinski; Eduard Vieta
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

Review 7.  Comorbid anxiety in bipolar disorder alters treatment and prognosis.

Authors:  Rif S El-Mallakh; Michael Hollifield
Journal:  Psychiatr Q       Date:  2008-05-20

8.  Effects of comorbid anxiety disorders on the longitudinal course of pediatric bipolar disorders.

Authors:  Regina Sala; Michael A Strober; David A Axelson; Mary Kay Gill; Josefina Castro-Fornieles; Tina R Goldstein; Benjamin I Goldstein; Wonho Ha; Fangzi Liao; Satish Iyengar; Shirley Yen; Heather Hower; Jeffrey Hunt; Daniel P Dickstein; Neal D Ryan; Martin B Keller; Boris Birmaher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-10-17       Impact factor: 8.829

9.  A systematic review of the evidence of the burden of bipolar disorder in Europe.

Authors:  Liberty Fajutrao; Julie Locklear; Jennifer Priaulx; Anne Heyes
Journal:  Clin Pract Epidemiol Ment Health       Date:  2009-01-23

10.  The clinical-familial correlates and naturalistic outcome of panic-disorder-agoraphobia with and without lifetime bipolar II comorbidity.

Authors:  Cristina Toni; Giulio Perugi; Franco Frare; Giuseppe Tusini; Konstantinos N Fountoulakis; Kareen K Akiskal; Hagop S Akiskal
Journal:  Ann Gen Psychiatry       Date:  2008-11-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.